Abeona Therapeutics Inc. Share Price & Technical Analysis
ABEO · $5.53 (+3.17%)
Healthcare / Biotechnology
$5.53
+3.17%
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargar…
Price chart
Seasonality
Jun has 2 positive and 3 negative years (last 5 years shown)
-4% return in Jun, 5% avg return in past 3 year Jun month.
10% return in 2026, 36% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -4% | 0% | -10% | 22% | 5% | -4% | – | – | – | – | – | – | 10% |
| 25 | -2% | -4% | -9% | 40% | -6% | -10% | 12% | 8% | -22% | -9% | 6% | 6% | 11% |
| 24 | -16% | 60% | 3% | -43% | 7% | -5% | 17% | 16% | 11% | 0% | -2% | -12% | 36% |
| 23 | -19% | -8% | 22% | 11% | 0% | 29% | -17% | 29% | -5% | -12% | 26% | 4% | 61% |
| 22 | -26% | 0% | 23% | -35% | -19% | 16% | -20% | -8% | -19% | 48% | -19% | -16% | -75% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Uptrend · Uptrend
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$308.06M
P/E ratio
5.69
52W high
$7.54
52W low
$4.00
Volume
11,17,963
Beta
1.35
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is Abeona Therapeutics Inc. share price today?
- Abeona Therapeutics Inc. (ABEO) last traded around $5.53 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ABEO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ABEO. Download the app for real-time alerts.
- How can I analyze Abeona Therapeutics Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.